AR032520A1 - Compuestos - Google Patents

Compuestos

Info

Publication number
AR032520A1
AR032520A1 ARP020100274A ARP020100274A AR032520A1 AR 032520 A1 AR032520 A1 AR 032520A1 AR P020100274 A ARP020100274 A AR P020100274A AR P020100274 A ARP020100274 A AR P020100274A AR 032520 A1 AR032520 A1 AR 032520A1
Authority
AR
Argentina
Prior art keywords
compounds
relates
present
methylbenzylamino
imidazo
Prior art date
Application number
ARP020100274A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR032520A1 publication Critical patent/AR032520A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invencion se refiere a nuevas formas cristalinas de la sal de clorhidrato de 2,3-dimetil-8(2etil-6metibencilamino)-imidazo[1,2-a]piridina-6carboxamida. Además, la presente invencion se refiere también al uso de dichos compuestos parta el tratamiento de desordenes gastrointestinales, a las composiciones farmacéuticas que los contienen y a los procedimientos para obtenerlos.
ARP020100274A 2001-02-01 2002-01-25 Compuestos AR032520A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100295A SE0100295D0 (sv) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
AR032520A1 true AR032520A1 (es) 2003-11-12

Family

ID=20282797

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020100274A AR032520A1 (es) 2001-02-01 2002-01-25 Compuestos

Country Status (3)

Country Link
AR (1) AR032520A1 (es)
SE (1) SE0100295D0 (es)
WO (1) WO2002060442A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100384842C (zh) 2002-11-19 2008-04-30 奥坦纳医药公司 8-取代的咪唑并吡啶类化合物
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
WO2002060442A1 (en) 2002-08-08
SE0100295D0 (sv) 2001-02-01

Similar Documents

Publication Publication Date Title
ECSP088413A (es) Preparación y uso de derivados de tetrahidropirrolo[3,2-c]piridin-4-ona para el tratamiento de la obesidad, trastornos psiquiátricos y neurológicos
UY27740A1 (es) Nuevos compuestos
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
AR052447A1 (es) Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034744A (es) Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
BG111017A (bg) Нови кристални и аморфна форми на съединението триазоло (4, 5- d)пиримидин
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
AR034897A1 (es) Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
ECSP066643A (es) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2
PE20040197A1 (es) Pirazolopiridinas sustituidas con carbamato
UY28510A1 (es) Compuestos quimicos
CR7080A (es) Sales tartrato de 5,8,14-triazatetraciclo [10.3.1.02,11.04,9] hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas.
HUP0402270A2 (hu) [1,2,4]Triazolo[1,5-c]pirimidin-5-il-aminok mint adenozin A2a receptor antagonisták és az ezeket tartalmazó gyógyszerkészítmények
AR024060A1 (es) Nuevos compuestos farmaceuticamente activos
UY28144A1 (es) Agentes terapéuticos
EA200700144A1 (ru) Производные пиридопиримидина, их получение, их применение в терапии
DOP2006000243A (es) Derivados de pirazina
UY28377A1 (es) Agentes terapeuticos
AR028250A1 (es) Imidazo [1,5-a]-pirido [3,2-e]-pirazinonas, la utilizacion de dichos compuestos y sus sales para la preparacion de medicamentos y los medicamentos asi preparados
DOP2002000390A (es) Sal citrato de 5,8 14-hiezatetraciclo [10.3.1.0 2,11. 0.4.9] hexadeca-2(11),3,5,8,9, pentaeno y composiciones farmaceuticas de las mismas
UY29741A1 (es) Sales de 1,5- diaril pirazol-3-carboxamidas, procesos de preparación, composeciones farmacéuticas que las contienen, aplicaciones y métodos de uso.
DK1534707T5 (da) Substituerede 2,4-dihydropyrrolo[3,4-b]quinolin-9-on-derivater egnede som phosphodiesteraseinhibitorer

Legal Events

Date Code Title Description
FB Suspension of granting procedure